MedTec Biolab, Inc., Hillsborough, NC 27278, USA.
Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Int J Environ Res Public Health. 2020 Mar 23;17(6):2124. doi: 10.3390/ijerph17062124.
Air pollution consists of highly variable and complex mixtures recognized as major contributors to morbidity and mortality worldwide. The vast number of chemicals, coupled with limitations surrounding epidemiological and animal studies, has necessitated the development of new approach methods (NAMs) to evaluate air pollution toxicity. These alternative approaches include in vitro (cell-based) models, wherein toxicity of test atmospheres can be evaluated with increased efficiency compared to in vivo studies. In vitro exposure systems have recently been developed with the goal of evaluating air pollutant-induced toxicity; though the specific design parameters implemented in these NAMs-based studies remain in flux. This review aims to outline important design parameters to consider when using in vitro methods to evaluate air pollutant toxicity, with the goal of providing increased accuracy, reproducibility, and effectiveness when incorporating in vitro data into human health evaluations. This review is unique in that experimental considerations and lessons learned are provided, as gathered from first-hand experience developing and testing in vitro models coupled to exposure systems. Reviewed design aspects include cell models, cell exposure conditions, exposure chambers, and toxicity endpoints. Strategies are also discussed to incorporate in vitro findings into the context of in vivo toxicity and overall risk assessment.
空气污染由高度可变和复杂的混合物组成,被认为是全球发病率和死亡率的主要因素。大量的化学物质,加上围绕流行病学和动物研究的限制,使得必须开发新的方法(NAMs)来评估空气污染的毒性。这些替代方法包括基于体外(细胞)的模型,其中与体内研究相比,可以更有效地评估测试大气的毒性。最近已经开发了体外暴露系统,目的是评估空气污染物引起的毒性;尽管这些基于 NAMs 的研究中实施的具体设计参数仍在不断变化。本综述旨在概述使用体外方法评估空气污染物毒性时需要考虑的重要设计参数,目的是在将体外数据纳入人体健康评估时提高准确性、重现性和有效性。本综述的独特之处在于,提供了实验方面的考虑因素和经验教训,这些都是从开发和测试与暴露系统耦合的体外模型中获得的第一手经验。综述的设计方面包括细胞模型、细胞暴露条件、暴露室和毒性终点。还讨论了将体外发现纳入体内毒性和整体风险评估背景的策略。